{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:26:43Z","timestamp":1774459603036,"version":"3.50.1"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Influenza presents a significant public health threat, as severe cases can lead to excessive inflammation and complications such as pneumonia or acute respiratory distress syndrome. Current antiviral agents targeting viral proteins may lead to the development of resistance, highlighting the need for new agents targeting host factors. Neurotransmitter receptors are vital for cellular signaling and cell cycle modulation, making them promising antiviral therapeutic targets. Recent research has demonstrated that screening libraries of compounds aimed at these receptors can help identify inhibitors that prevent the replication of various viruses, including filoviruses and SARS-CoV-2. We screened a neurotransmitter receptor modulator library in influenza-infected U937 cells and found that many adrenergic, histamine, dopamine, and serotonin receptor agonists and antagonists exhibit antiviral activity. We identified 20 candidate compounds with IC50 values below 20 \u03bcM, suggesting a critical role for these receptors in influenza replication. Three representative compounds (isoxsuprine, ciproxifan, and rotigotine) inhibited H1N1 replication in a dose-dependent manner in multiple cell lines, and were effective against H1N1, oseltamivir-resistant H1N1, H3N2, and influenza B strains. Mechanistic studies indicated that these compounds affect virus internalization during the early infection stages. In a mouse model of lethal influenza, isoxsuprine significantly decreased lung viral titers, mitigated pulmonary inflammation, and enhanced survival rates. These findings highlight neurotransmitter receptors as potential targets for developing novel anti-influenza agents, providing a foundation for further optimization of the identified compounds as potential therapeutic agents.<\/jats:p>","DOI":"10.3389\/fcimb.2025.1562650","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:26:03Z","timestamp":1745904363000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Screening of neurotransmitter receptor modulators reveals novel inhibitors of influenza virus replication"],"prefix":"10.3389","volume":"15","author":[{"given":"Yarou","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yirui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqin","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lefang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingjian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xulin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.coviro.2014.06.004","article-title":"Influenza virus\u2013glycan interactions","volume":"7","author":"Air","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"B2","first-page":"54","article-title":"Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs","volume-title":"Antiviral Research","author":"An","year":"2014"},{"key":"B3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-323-85662-1.00018-5","article-title":"Chapter 4 - Avian influenza A virus infections in humans: current knowledge to enhance host innate immunity to control Avian influenza","volume-title":"Pandemic Outbreaks in the 21st Century","author":"Anjana","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/glia.20077","article-title":"Synaptic and extrasynaptic neurotransmitter receptors in glial precursors\u2019 quest for identity","volume":"48","author":"Belachew","year":"2004","journal-title":"Glia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/2211-5463.13416","article-title":"Influenza antivirals and animal models","volume":"12","author":"Caceres","year":"2022","journal-title":"FEBS Open Bio"},{"key":"B6","doi-asserted-by":"publisher","first-page":"11790","DOI":"10.1073\/pnas.0803711105","article-title":"Epsin 1 is a cargo-specific adaptor for the clathrin-mediated endocytosis of the influenza virus","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1128\/jvi.01337-15","article-title":"Inhibition of Ebola and Marburg virus entry by G protein-coupled receptor antagonists","volume":"89","author":"Cheng","year":"2015","journal-title":"J. Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.14715\/cmb\/2023.69.13.3","article-title":"Antiviral resistance in influenza viruses","volume":"69","author":"Dom\u00ednguez","year":"2023","journal-title":"Cell. Mol. Biol. (Noisy-le-Grand France)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1099\/vir.0.059477-0","article-title":"Entry of influenza A virus: host factors and antiviral targets","volume":"95","author":"Edinger","year":"2014","journal-title":"J. Gen. Virol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3763","article-title":"A Ca2+-dependent signaling circuit regulates influenza A virus internalization and infection","volume":"4","author":"Fujioka","year":"2013","journal-title":"Nat. Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.virusres.2004.01.013","article-title":"Use of siRNAs to prevent and treat influenza virus infection","volume":"102","author":"Ge","year":"2004","journal-title":"Virus Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1006\/meth.2001.1261","article-title":"An overview of real-time quantitative PCR: applications to quantify cytokine gene expression","volume":"25","author":"Giulietti","year":"2001","journal-title":"Methods"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.2020.34.s1.05327","article-title":"Inhibition of Epstein-Barr virus by serotonin-dopamine antagonists","volume":"34","author":"Gorres","year":"2020","journal-title":"FASEB J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1071\/ma21044","article-title":"Avian influenza H5N1: still a pandemic threat","volume":"42","author":"Horwood","year":"2021","journal-title":"Microbiol. Aust."},{"key":"B15","doi-asserted-by":"publisher","first-page":"C1498","DOI":"10.1152\/ajpcell.00088.2007","article-title":"Dopamine induces apoptosis in young, but not in neonatal, neurons via Ca2+-dependent signal","volume":"293","author":"Iwatsubo","year":"2007","journal-title":"Am. J. Physiology-Cell Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/emboj.2010.13","article-title":"Architecture of a nascent viral fusion pore","volume":"29","author":"Lee","year":"2010","journal-title":"EMBO J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-4614-0980-9_9","article-title":"Influenza virus entry","volume":"726","author":"Luo","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22927-0","article-title":"Stimulation of alpha2-adrenergic receptors impairs influenza virus infection","volume":"8","author":"Matsui","year":"2018","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/v15122366","article-title":"Antiviral activity of probenecid and oseltamivir on influenza virus replication","volume":"15","author":"Murray","year":"2023","journal-title":"Viruses"},{"key":"B20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s004410000343","article-title":"Neurotransmitters as early signals for central nervous system development","volume":"305","author":"Nguyen","year":"2001","journal-title":"Cell Tissue Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/genes4020171","article-title":"Non-neuronal functions of the M2 muscarinic acetylcholine receptor","volume":"4","author":"Ockenga","year":"2013","journal-title":"Genes"},{"key":"B22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1128\/jvi.01434-06","article-title":"Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication","volume":"81","author":"Ozawa","year":"2006","journal-title":"J. Virol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7554\/elife.61700","article-title":"Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection","volume":"10","author":"Powell","year":"2021","journal-title":"eLife"},{"key":"B24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12","volume":"27","author":"Reed","year":"1938","journal-title":"American Journal of Epidemiology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2016.00272","article-title":"What do we really know about 5-HT1A receptor signaling in neuronal cells","volume":"10","author":"Rojas","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"10950","DOI":"10.1128\/jvi.05992-11","article-title":"Filamentous influenza virus enters cells via macropinocytosis","volume":"86","author":"Rossman","year":"2012","journal-title":"J. Virol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000141","article-title":"Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus","volume":"4","author":"Saeed","year":"2008","journal-title":"PLoS Pathog."},{"key":"B28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/cas.14670","article-title":"Activation of \u03b22-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells","volume":"112","author":"Sakakitani","year":"2020","journal-title":"Cancer Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1021\/acschemneuro.0c00499","article-title":"Cell cycle dependent modulation of membrane dipole potential and neurotransmitter receptor activity: role of membrane cholesterol","volume":"11","author":"Sarkar","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijbiomac.2020.02.064","article-title":"Catalytic activity and structural changes of catalase in the presence of Levothyroxine and Isoxsuprine hydrochloride","volume":"152","author":"Shahraki","year":"2020","journal-title":"Int. J. Biol. Macromolecules"},{"key":"B31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/17460441.2019.1560261","article-title":"Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains","volume":"14","author":"Shin","year":"2018","journal-title":"Expert Opin. Drug Discovery"},{"key":"B32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jphotobiol.2017.04.007","article-title":"Exploring isoxsuprine hydrochloride binding with human serum albumin in the presence of folic acid and ascorbic acid using multispectroscopic and molecular modeling methods","volume":"170","author":"Shiri","year":"2017","journal-title":"J. Photochem. Photobiology B: Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"10455","DOI":"10.1128\/jvi.76.20.10455-10464.2002","article-title":"Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis","volume":"76","author":"Sieczkarski","year":"2002","journal-title":"J. Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/infdis\/jiu377","article-title":"Repurposing of prochlorperazine for use against dengue virus infection","volume":"211","author":"Simanjuntak","year":"2014","journal-title":"J. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038307","article-title":"Host cell factors that interact with Influenza virus ribonucleoproteins","volume":"11","author":"Staller","year":"2020","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.idc.2010.07.001","article-title":"Antiviral drug resistance: mechanisms and clinical implications","volume":"24","author":"Strasfeld","year":"2010","journal-title":"Infect. Dis. Clinics North America"},{"key":"B37","first-page":"174","article-title":"6.11 - neurotransmitter receptors","volume-title":"Comprehensive Toxicology","author":"Suppiramaniam","year":"2017"},{"key":"B38","first-page":"109","volume-title":"Antiviral Drugs","author":"Tahir","year":"2024"},{"key":"B39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","article-title":"The pathology of Influenza virus infections","volume":"3","author":"Taubenberger","year":"2008","journal-title":"Annu. Rev. Pathology: Mech. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2018.02.005","article-title":"Antiviral resistance due to deletion in the neuraminidase gene and defective interfering-like viral polymerase basic 2 RNA of influenza A virus subtype H3N2","volume":"102","author":"Trebbien","year":"2018","journal-title":"J. Clin. Virol."},{"key":"B41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-815950-7.00009-6","article-title":"Chapter 9 - Signal transduction in Parkinson\u2019s disease: modulation of neurotransmission, symptomatology, and therapy","volume-title":"Genetics, neurology, Behavior, and Diet in Parkinson\u2019s Disease","author":"Volta","year":"2020"},{"key":"B42","first-page":"31","article-title":"Cell Cycle Inhibitors in Cancer Therapy. Cancer Drug Discovery and Development. Humana Press, Totowa, NJ","volume-title":"Cell Cycle Control of Transcription at the G1\/S Phase Transition","author":"Wijnen","year":"2003"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2429627","article-title":"Influenza neuraminidase mutations and resistance to neuraminidase inhibitors. Emerging Microbes & Infections","volume":"13","author":"Xu","year":"2024"},{"key":"B44","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.antiviral.2012.09.012","article-title":"Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains","volume":"96","author":"Yamada","year":"2012","journal-title":"Antiviral Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/s41401-020-00556-6","article-title":"Identification of SARS-CoV-2 entry inhibitors among already approved drugs","volume":"42","author":"Yang","year":"2020","journal-title":"Acta Pharmacologica Sin."},{"key":"B46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.5114\/ceji.2015.54602","article-title":"Role of \u03b17 nicotinic receptor in the immune system and intracellular signaling pathways","volume":"40","author":"Zdanowski","year":"2015","journal-title":"Cent. Eur. J. Immunol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1562650\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:26:06Z","timestamp":1745904366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1562650\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":46,"alternative-id":["10.3389\/fcimb.2025.1562650"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1562650","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"article-number":"1562650"}}